How has the HFpEF guidelines evolved with the advent of SGLT2i trials?

Document ID: PC-MY-102946

24/07/2023

Author: Boehringer Ingelheim

How has the HFpEF guidelines evolved with the advent of SGLT2i trials? from Let's Talk! - Prof. Andrew Coats

Click on the timestamp to jump to the topic you are interested in.

  • 00:38 The new universal definition of heart failure 01:17 Over the years we've seen an increase in the HFpEF patients 02:03 ESC 2021 recommendations (HFpEF) 02:50 EMPEROR-Preserved trial showed a beneficial effect on treating HFpEF 03:27 AHA/ACC/HFSA guidelines recommend SGLT2i in HFpEF

123,000
Views

100k 340

Related content

 
PC-MY-102946
Production date: July 2023